Author:
Shi Yin-Feng,Tian Zhong,Zhang Yang,Shen He-Bai,Jia Neng-Qin
Abstract
Abstract
Halloysites are cheap, abundantly available, and natural with high mechanical strength and biocompatibility. In this paper, a novel halloysite nanotube [HNT]-based gene delivery system was explored for loading and intracellular delivery of antisense oligodeoxynucleotides [ASODNs], in which functionalized HNTs [f-HNTs] were used as carriers and ASODNs as a therapeutic gene for targeting survivin. HNTs were firstly surface-modified with γ-aminopropyltriethoxysilane in order to facilitate further biofunctionalization. The f-HNTs and the assembled f-HNT-ASODN complexes were characterized by transmission electron microscopy [TEM], dynamic light scattering, UV-visible spectroscopy, and fluorescence spectrophotometry. The intracellular uptake and delivery efficiency of the complexes were effectively investigated by TEM, confocal microscopy, and flow cytometry. In vitro cytotoxicity studies of the complexes using MTT assay exhibited a significant enhancement in the cytotoxic capability. The results exhibited that f-HNT complexes could efficiently improve intracellular delivery and enhance antitumor activity of ASODNs by the nanotube carrier and could be used as novel promising vectors for gene therapy applications, which is attributed to their advantages over structures and features including a unique tubular structure, large aspect ratio, natural availability, rich functionality, good biocompatibility, and high mechanical strength.
Publisher
Springer Science and Business Media LLC
Subject
Condensed Matter Physics,General Materials Science
Reference24 articles.
1. Stahel RA, Zangemeister-Wittke U: Antisense oligonucleotides for cancer therapy-an overview. Lung Cancer 2003, 41: S81-S88.
2. Biroccio A, Leonetti C, Zupi G: The future of antisense therapy: combination with anticancer treatments. Oncogene 2003, 22: 6579–6587. 10.1038/sj.onc.1206812
3. White LK, Wright WE, Shay J: Telomerase inhibitors. Trends Biotechnol 2001, 19: 114–120. 10.1016/S0167-7799(00)01541-9
4. Sun C, Nettesheim D, Liu Z, Olejniczak ET: Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 2005, 11–17.
5. Altieri DC: Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003, 22: 8581–8589. 10.1038/sj.onc.1207113
Cited by
122 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献